이원철 (Pfizer, Inc.)님 | 한빛사연구자 > 한빛사

Pfizer, Inc.

최종업데이트 2020.11.07.

Organometallic hotspot engineering for ultrasensitive EC-SERS detection of pathogenic bacteria-derived DNAs
- Biosens. Bioelectron., 2022 Aug 15;210:114325 | https://doi.org/10.1016/j.bios.2022.114325
- 2022-08
- 바이오·의료융합
- 한빛사논문
- 이원철(University of Texas MD Anderson Cancer Center, Pfizer, Inc.)
Multiomics profiling of primary lung cancers and distant metastases reveals immunosuppression as a common characteristic of tumor cells with metastatic plasticity
- Genome Biol., Published: 04 November 2020, 21, Article number: 271 (2020) | https://doi.org/10.1186/s13059-020-02175-0
- 2020-11
- 한빛사논문
- 이원철(The University of Texas MD Anderson Cancer Center)
Evolution of genomic and T cell repertoire heterogeneity of malignant pleural mesothelioma under dasatinib treatment
- Clin. Cancer Res., Published Online First August 14, 2020 | doi: 10.1158/1078-0432.CCR-20-1767
- 2020-08
- 한빛사논문
The transcriptional landscape and mutational profile of lung adenocarcinoma
- Genome Res., Published in Advance September 13, 2012, doi: 10.1101/gr.145144.112
- 2012-09
- 의약학
- 한빛사논문, 상위피인용논문

연구자 ID

저자논문